SCHEMBL23861567

SCHEMBL23861567

CC(c1ccc(C(C)(c2c(O)ccc3ccc(O)cc23)c2c(O)ccc3ccc(O)cc23)cc1)(c1c(O)ccc2ccc(O)cc12)c1c(O)ccc2ccc(O)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 8/20 0.41
▸ ESR2 Q92731 6/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ TYR P14679 2/20 0.41
▸ NR1I2 O75469 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ MIF P14174 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ NFE2L2 Q16236 1/20 0.41
▸ MCL1 Q07820 1/20 0.39
▸ HPGD P15428 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ MPL P40238 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ AR P10275 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861411 0.95 ESR1 (0.41) ESR1ESR2HSD17B10ALDH1A1ALOX15
SCHEMBL23861444 0.92 ESR1 (0.50) ESR1ESR2HSD17B10ALDH1A1ALOX15
SCHEMBL23082042 0.89 ESR1 (0.48) ESR1ESR2ALDH1A1CYP2C9MPL
SCHEMBL23861565 0.88 ESR1 (0.40) ESR1ESR2HSD17B10ALDH1A1ALOX15
SCHEMBL23861487 0.88 CYP1A2 (0.46) ESR1ESR2LMNAMCL1TDP1
SCHEMBL9618414 0.86 ESR1 (0.47) ESR1ESR2HSD17B10ALDH1A1ALOX15
SCHEMBL23861513 0.84 LMNA (0.40) ESR1ESR2HSD17B10ALDH1A1ALOX15
SCHEMBL23861591 0.84 CYP2D6 (0.38) ESR1ESR2HSD17B10ALDH1A1LMNA
SCHEMBL23861415 0.83 ESR1 (0.47) ESR1ESR2CYP2C9CYP3A4HSD17B2
SCHEMBL2186567 0.83 LMNA (0.50) ESR1ESR2HSD17B10ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 ESR1 713/4885ESR2 1033/4885HSD17B10 552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback